ESR1 and breast cancer: Subsequently, the patient underwent 16α-[18F]fluoro-17β-estradiol (FES) PET/CT in the expectation that FES uptake in the pulmonary nodule would be selective and confirmatory for any potential estrogen receptor positive (ER+) breast cancer metastatic deposits, and thus allowing for proper staging and treatment.